Board of Directors
Carsten TradsMember of the Board
Carsten Trads holds a B.Sc. from Copenhagen Business School, complemented by management training from INSEAD and Harvard Business School.
Carsten has more than 30 years international experience within sales, marketing, operations, strategic planning and general management. Excecutive positions in companies such as Bang & Olufsen A/S, GN ReSound A/S and Plantronics Inc. From 2015 he has been the CEO and owner of C-Plus Consult, assisting smaller business startups.
Jeppe Krog RasmussenFounder & Chief Executive Officer (CEO), Member of the Board
Jeppe Krog Rasmussen, Founder and CEO at DanCann Pharma since its formation in 2018. Jeppe has been a part of the whole DanCann Pharma journey since its beginning back in March 2018, where he founded the Company. Jeppe is responsible for the strategic direction and operational execution of all processes relevant to DanCann Pharma.
In addition to DanCann Pharma Jeppe runs his investment company, JKR Investment Group ApS, where he manages his investment portfolio.
Magnus Østergaard DahlmannChairman of the Board
Magnus Østergaard Dahlmann holds a B.Sc. Magnus has as a senior executive more than 30 years international business experience within supply chain, sales, marketing, brand position and general management.
He has particular experience within mergers and acquisitions, change management and strategic- & operational business development. Executive positions at Solar A/S (DK), EVN GmbH (D), Klitsö AB (S) and Solar Elektro Engros AS (N).
Per WesterMember of the Board
Per Wester holds an MBA from Stockholm Business School and a B.Sc in Business and Administration from Linné University. Per has a long experience from starting and building companies as well as developing new pharmaceutical products in pre-clinical phase and launching new pharmaceutical products into markets.
As CEO Wester has managed several funding arrangements such as Private Placements, issuing of new shares, rights issues, IPO into Spotlight Stock Market and list change to Nasdaq First North Growth Market.